Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Macrogenics (MGNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 487,246
  • Shares Outstanding, K 42,259
  • Annual Sales, $ 157,740 K
  • Annual Income, $ -19,630 K
  • 36-Month Beta 2.55
  • Price/Sales 2.32
  • Price/Cash Flow N/A
  • Price/Book 1.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -1.04
  • Number of Estimates 7
  • High Estimate -0.60
  • Low Estimate -1.33
  • Prior Year 2.80
  • Growth Rate Est. (year over year) -137.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.16 +3.32%
on 01/22/19
14.60 -21.03%
on 01/11/19
-0.26 (-2.21%)
since 12/21/18
3-Month
11.16 +3.32%
on 01/22/19
19.15 -39.79%
on 11/08/18
-6.60 (-36.40%)
since 10/22/18
52-Week
11.16 +3.32%
on 01/22/19
32.74 -64.78%
on 03/08/18
-7.89 (-40.63%)
since 01/22/18

Most Recent Stories

More News
After Yesterday's Decline of 8.12%, Macrogenics Inc Offers Investors Better Value

Macrogenics Inc (NASDAQ:MGNX) traded in a range yesterday that spanned from a low of $11.31 to a high of $11.89. Yesterday, the shares fell 8.1%, which took the trading range below the 3-day low of $12.19...

MGNX : 11.53 (-6.34%)
What Lies Ahead for Abbott (ABT) Stock This Earnings Season?

Abbott (ABT) is showing a steady rise on a healthy growth graph within its Diabetes Care business for a considerable period.

MGNX : 11.53 (-6.34%)
ABT : 71.49 (+0.10%)
NSTG : 20.20 (-0.25%)
CMRX : 2.60 (-3.70%)
4 Medical Product Stocks Likely to Top Q4 Earnings Estimates

Given the encouraging performance of the medical products industry for most part of 2018, it will be interesting see how the constituent companies perform in Q4.

MGNX : 11.53 (-6.34%)
NXTM : 28.36 (-0.49%)
NSTG : 20.20 (-0.25%)
CMRX : 2.60 (-3.70%)
Macrogenics Inc Down 34.1% Since SmarTrend Downtrend Call (MGNX)

SmarTrend identified a Downtrend for Macrogenics Inc (NASDAQ:MGNX) on October 8th, 2018 at $20.42. In approximately 3 months, Macrogenics Inc has returned 34.12% as of today's recent price of $13.45.

MGNX : 11.53 (-6.34%)
Medical Products Industry Gathering Steam: 3 Stocks to Buy

The Medical Products market is gaining traction from a firm exposure to robotics, medical mechatronics and the bipartisan two-year suspension of a 2.3% excise tax on MedTech manufacturers.

MGNX : 11.53 (-6.34%)
SRDX : 47.83 (+0.44%)
BLFS : 12.40 (+1.64%)
MacroGenics to Present at the 37th Annual J.P. Morgan Healthcare Conference

EQNX::TICKER_START (Nasdaq:MGNX), EQNX::TICKER_END

MGNX : 11.53 (-6.34%)
JPM : 102.94 (-1.58%)
Downtrend Call Working As Macrogenics Inc Stock Falls 38.8% (MGNX)

SmarTrend identified a Downtrend for Macrogenics Inc (NASDAQ:MGNX) on October 8th, 2018 at $20.42. In approximately 3 months, Macrogenics Inc has returned 38.77% as of today's recent price of $12.50.

MGNX : 11.53 (-6.34%)
The Zacks Analyst Blog Highlights: Chimerix, MacroGenics, Rockwell Medical, TG Therapeutics and Valeritas

The Zacks Analyst Blog Highlights: Chimerix, MacroGenics, Rockwell Medical, TG Therapeutics and Valeritas

TGTX : 4.36 (-3.54%)
MGNX : 11.53 (-6.34%)
VLRX : 0.41 (unch)
RMTI : 3.13 (-9.80%)
CMRX : 2.60 (-3.70%)
5 Beaten-Down Medical Product Stocks to Rebound in 2019

As the Medical product industry is witnessing temporary sluggishness, a sneak peek into some possible outperformers in 2019 could be a great idea for investors.

MGNX : 11.53 (-6.34%)
TGTX : 4.36 (-3.54%)
ABT : 71.49 (+0.10%)
VLRX : 0.41 (unch)
RMTI : 3.13 (-9.80%)
CMRX : 2.60 (-3.70%)
PIMCO Closed-End Funds Declare Special Year-End Distribution

The Board of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds") has declared a special year-end distribution for certain Fund's common shares as summarized...

IPG : 21.65 (-2.70%)
NGVC : 15.75 (-2.42%)
STC : 43.17 (-0.99%)
ATUS : 18.73 (-1.78%)
RBA : 36.28 (+0.08%)
MHK : 126.72 (+0.08%)
NVCR : 46.62 (+0.37%)
CVSI : 4.6600 (+6.39%)
AC : 39.07 (-3.82%)
BSX : 37.26 (-1.14%)
HON : 139.82 (-1.43%)
POTND : 0.0200 (+32.45%)
PRTT : 1.2500 (-30.56%)
TARSD : 0.2033 (-1.64%)
NKE : 80.75 (+0.37%)
ROIC : 16.78 (-0.59%)
DGX : 86.18 (-0.99%)
EIX : 54.21 (-1.22%)
GARLF : 0.0850 (-2.19%)
MRNA : 15.56 (-6.77%)
MSPC : 0.0002 (unch)
RYAAY : 69.09 (+5.08%)
BA : 357.90 (-1.87%)
BDC : 50.92 (-3.69%)
BC : 48.99 (-2.68%)
OXFD : 14.46 (-2.82%)
NDAQ : 83.40 (+0.31%)
TTOO : 3.60 (-0.28%)
DMAC : 3.60 (-1.10%)
CMCM : 6.50 (-0.76%)
ALGN : 216.16 (-1.79%)
ABM : 35.23 (-2.08%)
RTN : 163.71 (-1.03%)
IESC : 17.02 (+0.71%)
KIDS : 34.06 (+0.06%)
CYL.VN : 0.175 (+12.90%)
FLIR : 44.73 (-1.45%)
NETC.CN : 0.140 (+7.69%)
SLCA : 13.36 (-3.95%)
BANX : 19.85 (+0.61%)
APOG : 33.82 (-1.26%)
RBBN : 5.53 (-2.47%)
SPLIF : 0.2100 (-0.43%)
SO : 47.07 (-0.32%)
SNWV : 0.2170 (-9.01%)
ACB : 6.19 (-3.88%)
CE : 95.73 (-2.13%)
QILFF : 0.1900 (-4.62%)
QILFD : 0.2331 (-29.98%)
MANH : 47.82 (-1.14%)
MKL : 1,035.00 (-3.11%)
HAL : 31.26 (-3.07%)
LZB : 29.68 (-1.49%)
INTC : 48.27 (-1.87%)
APHQF : 11.5700 (-3.05%)
AMZN : 1,632.17 (-3.77%)
ACHC : 28.32 (-2.31%)
TX : 28.26 (-2.18%)
SRPT : 120.28 (-2.05%)
JOUT : 63.52 (-4.95%)
CCAN : 0.2650 (+10.42%)
OBMP : 0.0103 (-6.36%)
ELY : 16.51 (-2.77%)
DY : 57.47 (-3.14%)
HIPH : 0.0530 (-5.19%)
POTN : 0.1058 (-0.94%)
JWN : 47.07 (-0.95%)
SYF : 26.55 (+1.03%)
AQUA : 10.04 (-4.02%)
NWVCF : 1.0517 (+0.16%)
USYNF : 3.1500 (+5.77%)
EMR : 63.01 (-1.05%)
BXE : 0.43 (-2.27%)
HSY : 108.31 (+0.16%)
EW : 168.29 (-0.07%)
SCQBD : 0.7420 (+1.08%)
PTS.TO : 13.11 (+0.15%)
PSX : 93.00 (-2.41%)
MVIS : 0.79 (-1.86%)
PCI : 22.27 (-1.63%)
PCN : 15.42 (+0.72%)
AVT : 41.25 (-2.92%)
MGNX : 11.53 (-6.34%)
ICBK : 18.21 (-4.26%)
DLR : 105.10 (-2.00%)
RHI : 59.76 (-1.82%)
YVR : 2.37 (-1.66%)
PTY : 16.08 (+0.63%)
PDI : 31.12 (-1.27%)
TNXP : 1.93 (-6.31%)
GBT : 47.82 (-2.15%)
QI.VN : 0.290 (-27.50%)
TSRO : 74.96 (+0.03%)
RHP : 76.42 (-0.31%)
NKTR : 44.76 (-3.12%)
GOOG : 1,070.52 (-2.53%)
JBLU : 17.37 (-1.31%)
IGC : 2.49 (unch)
WBT : 13.21 (-0.53%)
WRY.VN : 0.045 (+800.00%)
SAPIF : 28.6410 (-1.69%)
WSO : 144.38 (-0.99%)
LMT : 279.59 (-1.16%)
CMCSA : 34.97 (-3.42%)
HSDT : 7.65 (-8.16%)
GWRE : 84.94 (-0.90%)
CLGX : 36.05 (-1.39%)
FNSR : 21.21 (-2.35%)
SONS : 7.83 (+2.76%)
DEWM : 0.0010 (-9.09%)
SLG : 88.34 (-1.01%)
UPS : 102.68 (+1.06%)
PFN : 9.82 (+0.10%)
KMB : 115.23 (-1.40%)
ANZ.VN : 0.075 (+7.14%)
TAOP : 1.14 (-5.00%)
NSU : 4.48 (-0.88%)
CBDS : 3.5100 (+2.63%)
CTXS : 108.25 (-0.45%)
PCOM : 9.80 (-0.71%)
HTHT : 31.16 (-10.79%)
MAN : 73.13 (-1.76%)
CNK : 39.56 (-3.32%)
AMAT : 34.44 (-3.56%)
FMCC : 2.5100 (+5.46%)
MRK : 75.83 (-0.05%)
ATOS : 1.38 (+2.99%)
WTCRF : 0.0138 (unch)
MLRKF : 0.0835 (-6.07%)
GAZ-UN.VN : 0.600 (unch)
MEOH : 55.91 (-5.17%)
COOL : 17.33 (-0.69%)
SAVE : 58.06 (-2.19%)
PCRX : 40.46 (+1.05%)
RNLSY : 12.7650 (-1.47%)
COL : 141.04 (-0.42%)
COR : 93.21 (-1.15%)
IDXG : 1.03 (-4.63%)
MCD : 184.57 (+1.10%)
ETST : 0.8500 (+19.72%)
QNIIF : 0.7100 (-2.62%)
PII : 85.45 (-3.25%)
AMRS : 3.44 (-4.18%)
SON : 54.85 (+0.07%)
MCK : 125.87 (-0.63%)
APHA : 7.08 (+5.99%)
MCO : 155.48 (-2.46%)
GSKY : 11.00 (-0.09%)
LH : 135.70 (-1.45%)
SAP.TO : 38.67 (-1.60%)
ODFL : 132.90 (-2.73%)
NEU : 401.66 (+0.28%)
ORTX : 12.90 (-3.15%)
BXE.TO : 0.55 (-3.51%)
GWPRF : 11.8700 (+6.23%)
PZN : 8.49 (-3.41%)
RBX.VN : 0.075 (unch)
RNG : 88.78 (-2.71%)
SPG : 173.26 (-0.40%)
TRVN : 0.53 (-3.45%)
AMC : 13.51 (-6.57%)
UTX : 111.06 (-2.49%)
AMD : 19.76 (-4.86%)
NDLS : 7.45 (-1.46%)
MPWR : 120.98 (-3.04%)
KGKG : 0.0580 (+3.94%)
FRO-UN.VN : 0.550 (unch)
DMCAF : 0.2660 (-5.10%)
IRMTF : 11.9721 (-0.40%)
BOX : 19.45 (-2.16%)
IQST : 2.5000 (+25.00%)
ASPS : 23.23 (-2.72%)
HMNY : 0.01 (unch)
ROP : 274.70 (-2.60%)
GOVB : 14.5000 (unch)
PKO : 25.55 (-1.01%)
MYGN : 28.89 (-2.63%)
CRL : 117.59 (-1.36%)
GLPH : 0.0220 (-12.00%)
BXXRF : 0.0051 (-74.50%)
ADTN : 11.78 (-0.93%)
GRNH : 0.0200 (unch)
NS : 25.65 (-2.77%)
LTS : 2.99 (-3.55%)
INT : 23.97 (-1.36%)
INPX : 2.28 (+2.24%)
GSPT : 0.0600 (-50.00%)
MRO.VN : 0.110 (+10.00%)
COST : 212.40 (-0.56%)
EFX : 103.62 (-0.59%)
BMRN : 95.66 (-2.08%)
SPGI : 187.29 (-0.72%)
IGCC : 0.3940 (+3.41%)
PYPL : 89.94 (-1.29%)
LHSIF : 0.7526 (-0.97%)
TDY : 217.39 (-3.44%)
AZPN : 88.93 (-2.24%)
ENW.VN : 1.410 (+2.92%)
DMA.VN : 4.630 (-2.11%)
SNAP : 5.93 (-4.05%)
KSU : 108.45 (-1.87%)
MERC : 14.61 (-1.08%)
DVA : 56.85 (-0.91%)
UNI.VN : 3.700 (-0.27%)
MGI : 2.21 (+0.45%)
IGAP : 0.2310 (-57.92%)
FIT : 6.06 (+0.17%)
RAD : 0.94 (-3.51%)
LDSR : 0.0042 (+7.69%)
CYLYF : 0.1108 (+14.23%)
PMX : 11.38 (-1.04%)
ROBXF : 0.1851 (+262.94%)
BRO : 28.32 (-1.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade MGNX with:

Business Summary

MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics...

See More

Key Turning Points

2nd Resistance Point 12.78
1st Resistance Point 12.15
Last Price 11.53
1st Support Level 11.03
2nd Support Level 10.54

See More

52-Week High 32.74
Fibonacci 61.8% 24.50
Fibonacci 50% 21.95
Fibonacci 38.2% 19.40
Last Price 11.53
52-Week Low 11.16

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar